DVA

Davita Inc

• NASDAQ·13h ago

  DaVita Breaks Below 200-Day Moving Average - Notable for DVA

• NASDAQ·11/03 21:43

  Hormel Foods Now #495 Largest Company, Surpassing DaVita

• PR Newswire·11/03 21:05

  DaVita Inc. to Participate in Upcoming Investor Conferences

• Dow Jones·11/02 21:41

  DaVita Is Maintained at Buy by UBS

• Dow Jones·11/02 20:46

  DaVita Is Maintained at Equal-Weight by Barclays

• Dow Jones·11/02 20:46

  DaVita Price Target Cut to $216.00/Share From $224.00 by Barclays

• Dow Jones·11/02 17:18

  DaVita Is Maintained at Buy by TD Cowen

• TipRanks·11/02 13:02

  DaVita price target raised to $228 from $220 at TD Cowen

• TipRanks·11/02 11:15

  DaVita price target raised to $287 from $270 at UBS

• TipRanks·11/02 10:35

  DaVita price target lowered to $216 from $224 at Barclays

• TipRanks·11/02 09:20

  Analysts Have Conflicting Sentiments on These Healthcare Companies: DaVita (DVA) and Retension Pharmaceuticals Inc (RTSN)

• TipRanks·10/30 12:11

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tenet Healthcare (THC), Eli Lilly & Co (LLY) and DaVita (DVA)

• NASDAQ·10/30 04:13

  DaVita Inc. Reports Third Quarter 2026 Results and Updates 2026 Guidance

• TipRanks·10/29 20:13

  DaVita reports Q3 EPS $3.82, consensus $3.57

• TipRanks·10/29 20:12

  DaVita narrows FY26 adjusted EPS to $14.30-$15.20 from $14.10-$15.20